CEACAM5 and neoplasm: Several clinical markers are related to the prognoses of SCLC patients, including tumour stage, sex, serum carcinoembryonic antigen (CEA) and lactate dehydrogenase (LDH), and indicate a high tumour burden and a poor prognosis [3–7].